EARL2与EARL1 [18F]FDG PET-CT性能标准在头颈部鳞状细胞癌中的定量与临床意义
本研究纳入49例头颈部鳞状细胞癌患者,比较EARL2与EARL1重建图像的定量参数及淋巴结分期影响,发现EARL2下SUVmax与SURmax显著升高,且部分淋巴结评分上调导致18%患者淋巴结分期改变。
要点
- EARL2较EARL1重建的原发肿瘤及淋巴结SUVmax升高16.5%、SURmax升高9.6%(p < 0.001)。
- EARL1上评分为2的淋巴结中38%(11/29)在EARL2上升为3分,致18%(6/33)患者淋巴结分期改变。
- 两种重建间MTV绝对差异小(< 1.0 cm3),但相对阈值法下EARL2的MTV降低、静态阈值法下升高。
核心结论
- 使用EARL2方法重建PET图像较EARL1产生更高的SUVmax和SURmax,并在相当数量患者中导致淋巴结分期上调。
研究设计与样本
- 纳入49例连续头颈部鳞状细胞癌患者,对每例单次[18F]FDG PET-CT扫描分别重建EARL1与EARL2图像。
- 在CT上勾画原发肿瘤及≥ 5 mm的非坏死淋巴结,计算SUVmax与SURmax(SUVmax以颈髓摄取归一化)。
- 采用自适应阈值、SUV2.5/3.5/4.5、SUR2.5/3.5/4.5、MAX40%/50%等分割方法比较MTV与总病灶糖酵解。
- 由两名核医学医师在不同场合独立采用4分法对淋巴结进行视觉评分。
主要发现
- EARL2较EARL1的原发肿瘤及淋巴结SUVmax显著升高16.5%,SURmax显著升高9.6%(p < 0.001)。
- SUVmax与SURmax的组间比例差异随肿瘤体积增大而减小(p < 0.001)。
- 两种重建间MTV绝对差异小(< 1.0 cm3),与分割方法无关。
- 相对阈值法(自适应阈值、MAX40%/50%)下EARL2的MTV降低,静态SUV或SUR阈值法下MTV升高。
- EARL1评分为2的淋巴结中38%(11/29)在EARL2上升为3分,导致18%(6/33)患者淋巴结分期改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The EANM Research Ltd. (EARL) guidelines give recommendations for harmonization of [18F]FDG PET-CT image acquisition and reconstruction, aiming to ensure reproducibility of quantitative data between PET scanners. Recent technological advancements in PET-CT imaging resulted in an updated version of the EARL guidelines (EARL2). The aim of this study is to compare quantitative [18F]FDG uptake metrics of the primary tumor and lymph nodes in patients with head and neck squamous cell carcinoma (HNSCC) on EARL2 versus EARL1 reconstructed images and to describe clinical implications for nodal staging and treatment. METHODS: Forty-nine consecutive patients with HNSCC were included. For all, both EARL1 and EARL2 images were reconstructed from a singular [18F]FDG PET-CT scan. Primary tumors and non-necrotic lymph nodes ≥ 5 mm were delineated on CT-scan. In the quantitative analysis, maximum standardized uptake values (SUVmax) and standardized uptake ratios (SURmax, i.e., SUVmax normalized to cervical spinal cord uptake) were calculated for all lesions on EARL1 and EARL2 reconstructions. Metabolic tumor volume (MTV) and total lesion glycolysis were compared between EARL1 and EARL2 using different segmentation methods (adaptive threshold; SUV2.5/3.5/4.5; SUR2.5/3.5/4.5; MAX40%/50%). In the qualitative analysis, each lymph node was scored independently by two nuclear medicine physicians on both EARL1 and EARL2 images on different occasions using a 4-point scale. RESULTS: There was a significant increase in SUVmax (16.5%) and SURmax (9.6%) of primary tumor and lymph nodes on EARL2 versus EARL1 imaging (p < 0.001). The proportional difference of both SUVmax and SURmax between EARL2 and EARL1 decreased with increasing tumor volume (p < 0.001). Absolute differences in MTVs between both reconstructions were small (< 1.0 cm3), independent of the segmentation method. MTVs decreased on EARL2 using relative threshold methods (adaptive threshold; MAX40%/50%) and increased using static SUV or SUR thresholds. With visual scoring of lymph nodes 38% (11/29) of nodes with score 2 on EARL1 were upstaged to score 3 on EARL2, which resulted in an alteration of nodal stage in 18% (6/33) of the patients. CONCLUSIONS: Using the EARL2 method for PET image reconstruction resulted in higher SUVmax and SURmax compared to EARL1, with nodal upstaging in a significant number of patients.
引用
- Cox MC, Jurcka T, Arens AIJ, et al. Quantitative and clinical implications of the EARL2 versus EARL1 [18F]FDG PET-CT performance standards in head and neck squamous cell carcinoma. EJNMMI Res. 2023. PMID: 37878160. doi:10.1186/s13550-023-01042-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。